DUBLIN, June 9, 2022 /PRNewswire/ — The “Global Biopharmaceutical Third Party Logistics Market (2022-2027) by Supply Chan, Service, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Biopharmaceutical Third Party Logistics Market is estimated to be USD 105.15 Bn in 2022 and is projected to reach USD 200.95 Bn by 2027, growing at a CAGR of 13.83%.
Market Dynamics
Market dynamics are forces that impact the prices and behaviors of the Global Biopharmaceutical Third Party Logistics Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.
As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are Agility, CEVA Logistics, Coyote Logistics, DHL International, Echo GlobalLogistics, Expeditors, FedEx, Mahindra Logistics, United Parcel Service of America, XPO Logistics, etc.
Countries Studied
- America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Biopharmaceutical Third Party Logistics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The report analyses the Global Biopharmaceutical Third Party Logistics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Biopharmaceutical Third Party Logistics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Trend of Outsourcing Logistics in Developing Countries
4.1.2 Soaring Demand for Logistics in Healthcare and Pharmaceutical Industry
4.1.3 Surge in the Number of Biosimilar Launches
4.2 Restraints
4.2.1 Last Mile Logistics Problem
4.3 Opportunities
4.3.1 Increasing Adoption of Retrieval Systems and Automated Storage
4.3.2 Growing Number of Patients Suffering from Various Diseases
4.3.3 Fostering Investment in R&D for Innovative Drugs
4.4 Challenges
4.4.1 Data Breaches and Other Security Threats
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Biopharmaceutical Third Party Logistics Market, By Supply Chan
6.1 Introduction
6.2 Cold Chain
6.3 Non-Cold Chain
7 Global Biopharmaceutical Third Party Logistics Market, By Service
7.1 Introduction
7.2 Transportation
7.2.1 Air Freight
7.2.2 Overland
7.2.3 Sea Freight
7.3 Warehousing and Storage
8 Americas’ Biopharmaceutical Third Party Logistics Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Biopharmaceutical Third Party Logistics Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Biopharmaceutical Third Party Logistics Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Biopharmaceutical Third Party Logistics Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Agility
13.2 Americold
13.3 AmerisourceBergen
13.4 APL Logistic
13.5 Burris Logistics
13.6 CH Robinson
13.7 CEVA Logistics
13.8 Coyote Logistics
13.9 DACHSER Transportation
13.10 DB Schenker
13.11 DGS Translogistics
13.12 DHL International
13.13 Echo GlobalLogistics
13.14 Expeditors
13.15 FedEx
13.16 Kerry Logistics Network
13.17 KUEHNE + NAGEL
13.18 Mahindra Logistics
13.19 Panalpina International Logistics Services
13.20 Penske Logistics
13.21 Ryder Supply Chain Solutions
13.22 SF Express
13.23 Total Quality Logistics
13.24 TransGroup GlobalLogistic
13.25 United Parcel Service of America
13.26 XPO Logistics
14 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/d0rqaz
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
